Q2 2024 Holdings
Filed 2024-08-14 | 68 holdings | $6.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $536.7M | 1,915,862 | 8.3% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $380.8M | 17,687,772 | 5.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $373.1M | 4,634,331 | 5.8% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $359.8M | 8,806,838 | 5.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $281.4M | 654,430 | 4.4% |
| Natera Inc(NTRA) | COM | 632307104 | $280.8M | 2,593,323 | 4.3% |
| Merus N V | COM | N5749R100 | $246.7M | 4,169,393 | 3.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $243.9M | 3,640,108 | 3.8% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $226.1M | 7,393,127 | 3.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $225.4M | 6,387,138 | 3.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $222.7M | 13,707,506 | 3.4% |
| Bruker Corp(BRKR) | COM | 116794108 | $219.8M | 3,444,095 | 3.4% |
| Masimo Corp(MASI) | COM | 574795100 | $184.2M | 1,462,400 | 2.9% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $183.2M | 5,286,404 | 2.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $170.1M | 7,056,988 | 2.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $165.0M | 4,869,798 | 2.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $147.4M | 2,721,158 | 2.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $134.0M | 3,259,927 | 2.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $133.6M | 742,105 | 2.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $127.4M | 5,431,985 | 2.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $121.6M | 2,675,703 | 1.9% |
| Immatics N.v(IMTX) | SHS | N44445109 | $116.2M | 10,000,000 | 1.8% |
| Radnet Inc(RDNT) | COM | 750491102 | $109.4M | 1,856,010 | 1.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $106.7M | 2,712,096 | 1.7% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $92.8M | 3,412,486 | 1.4% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $90.1M | 202,456 | 1.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $79.0M | 2,967,897 | 1.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $76.6M | 3,258,360 | 1.2% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $67.0M | 4,078,122 | 1.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $59.7M | 3,557,347 | 0.9% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $59.5M | 5,480,577 | 0.9% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $59.1M | 7,378,548 | 0.9% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $57.1M | 4,224,838 | 0.9% |
| Orchestra Biomed Hldgs Inc(OBIO) | COM | 68572M106 | $45.8M | 5,620,640 | 0.7% |
| Glaukos Corp(GKOS) | COM | 377322102 | $45.7M | 386,291 | 0.7% |
| CG Oncology Inc(CGON) | COM | 156944100 | $42.4M | 1,344,074 | 0.7% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $42.1M | 18,800,299 | 0.7% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $39.0M | 1,070,565 | 0.6% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $38.8M | 3,327,129 | 0.6% |
| Vericel Corp(VCEL) | COM | 92346J108 | $36.8M | 801,397 | 0.6% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $36.2M | 5,845,956 | 0.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $18.4M | 1,052,630 | 0.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $17.3M | 666,667 | 0.3% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $15.4M | 1,454,273 | 0.2% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $14.9M | 863,389 | 0.2% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $14.0M | 400,000 | 0.2% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $13.9M | 1,852,711 | 0.2% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $12.1M | 2,298,662 | 0.2% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $10.2M | 1,133,787 | 0.2% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $9.8M | 502,856 | 0.2% |